Show simple item record

The solid progress of nanomedicine

dc.contributor.authorMartins, J. P.
dc.contributor.authordas Neves, J.
dc.contributor.authorDe La Fuente Freire, María 
dc.contributor.authorCelia, C.
dc.contributor.authorFlorindo, H.
dc.contributor.authorGuenday-Tureli, N.
dc.contributor.authorPopat, A.
dc.contributor.authorSantos, J. L.
dc.contributor.authorSousa, F.
dc.contributor.authorSchmid, R.
dc.contributor.authorWolfram, J.
dc.contributor.authorSarmento, B.
dc.contributor.authorSantos, H. A.
dc.date.accessioned2022-05-05T08:27:47Z
dc.date.available2022-05-05T08:27:47Z
dc.date.issued2020
dc.identifier.issn2190-393X
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/32141035es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16671
dc.description.abstractThis commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract.en
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshNational Cancer Institute (U.S.)*
dc.subject.meshHumans*
dc.subject.meshNanomedicine*
dc.subject.meshFocus Groups*
dc.subject.meshNeoplasms*
dc.titleThe solid progress of nanomedicineen
dc.typeJournal Articlees
dc.authorsophosMartins, J. P.;das Neves, J.;de la Fuente, M.;Celia, C.;Florindo, H.;Guenday-Tureli, N.;Popat, A.;Santos, J. L.;Sousa, F.;Schmid, R.;Wolfram, J.;Sarmento, B.;Santos, H. A.
dc.identifier.doi10.1007/s13346-020-00743-2
dc.identifier.pmid32141035
dc.identifier.sophos39815
dc.issue.number3es
dc.journal.titleDRUG DELIVERY AND TRANSLATIONAL RESEARCHes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)es
dc.page.initial726es
dc.page.final729es
dc.rights.accessRightsopenAccess
dc.subject.decsgrupos focales*
dc.subject.decsnanomedicina*
dc.subject.decshumanos*
dc.subject.decsneoplasias*
dc.subject.decsNational Cancer Institute (U.S.)*
dc.subject.keywordIDISes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number10es


Files in this item

Download/Open
Name:
39815-1327.pdf
Size:
252.4Kb
Format:
PDF
Description:
Drug Deliv Transl Res. 2020 Jun;10(3):726-729

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional